New Delhi, May 20 -- Zydus Lifesciences share price surged over 6% on Wednesday, 20 May, after the company reported strong Q4FY26 earnings and announced a share buyback plan. The pharmaceutical major posted a 14.6% year-on-year rise in consolidated net profit to Rs.1,592.9 crore for the quarter ended 31 March, supported by robust growth in its consumer wellness business.

Revenue from operations rose to Rs.7,587 crore from Rs.6,527.9 crore in the year-ago period. The pharma business reported revenue of Rs.5,643.6 crore, up 4.9% YoY, while the consumer wellness segment recorded sharp growth with revenue increasing to Rs.1,463.3 crore from Rs.908.1 crore a year ago.

The company's board approved a share buyback worth up to Rs.1,100 crore at...